This inventor holds 9 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents. Top assignees: Sanofi-A Ventis Deutschland Gmbh, Sanofi-Aventis. Active years: 2007-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Paris, FR (2011)
- Combs la Ville, FR (2007 - 2013)
Company Filing History:
Years Active: 2007-2013
Title: The Innovations of Jean-Francois Deleuze
Introduction
Jean-Francois Deleuze is a notable inventor based in Combs la Ville, France. He has made significant contributions to the field of medical science, particularly in identifying risks associated with thrombogenic disorders and diabetes. With a total of nine patents to his name, Deleuze's work has the potential to impact patient care and treatment options.
Latest Patents
One of his latest patents is a method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism. This invention aims to identify risks for conditions such as atrial fibrillation, stroke, and coronary heart disease. Another significant patent involves the association of the EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis or pulmonary embolism. This method helps in identifying an increased risk for these conditions based on specific amino acid exchanges in the EDG5 protein.
Career Highlights
Throughout his career, Jean-Francois Deleuze has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis. His work has been instrumental in advancing medical research and developing innovative solutions for complex health issues.
Collaborations
Deleuze has collaborated with notable professionals in his field, including Detlef Kozian and Sylvain Ricard. These partnerships have contributed to the success of his inventions and the advancement of medical knowledge.
Conclusion
Jean-Francois Deleuze's contributions to medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the identification and treatment of serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile